...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> Sartorius Stedim Biotech Presents Virosart® Media
06/13/16
> New Data Shows Agendia’s MammaPrint® can Prevent Under and Over Treatment of Breast Cancer Patients with an Intermediate/Indeterminate OncotypeDx Recurrence Score
06/07/16
> New On-line SPE Cartridges from Biotage
06/07/16
> Fujifilm Diosynth Announces Collaboration on a New 20,000-Liter Microbial Biologics Facility for Use by Its Contract Development and Manufacturing Customers
06/06/16
> Ganymed's IMAB362 Extends Survival in Gastric Cancer
06/05/16
> BioGenes and Eurofins BioPharma Product Testing Munich to Cooperate in the Area of HCP Analysis
06/03/16
> Emperra Partners with the Federal Initiative "German Accelerator Life Sciences" to Expand to US
06/03/16
> Agendia Appoints Dr. Gabriel Hortobagyi as Chairman to their Medical Advisory Board
06/01/16
> Merus N.V. Signs Commercial Multi-Product License for ProBioGen’s GlymaxX® ADCC Enhancement Technology
06/01/16
> ChemConnection and Cristal Therapeutics Announce Successful GMP Production of CriPec® Docetaxel for Phase 1/2a Clinical Trials
06/01/16
> Clinical Study in UK to Evaluate ReGenerCell™ for Diabetic Foot Ulcer Treatment
05/31/16
> Evercyte and VTU Technology Collaborate On Development of Recombinant Media Supplements
05/24/16
> ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics
05/18/16
> Ganymed to Present Exciting Phase II Clinical Data for IMAB362 in Gastroesophageal Cancer at ASCO 2016 Annual Meeting
05/17/16
> Vetter is a Winner of the AbbVie TRIUMPH AWARD
05/11/16
> LDC and Boehringer Ingelheim Join Forces to Discover a Novel Approach for the Treatment of Schizophrenia
05/11/16
> EMA/CHMP Adopts Positive Opinion for ITM´s EndolucinBeta®
05/10/16
> RedHill Biopharma Announces National Cancer Institute Grant Supporting YELIVA™ Phase II Hepatocellular Carcinoma Study
05/05/16
> Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference
05/04/16
> Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies
05/03/16
> CyTuVax Reports Interim Results of the Phase I Clinical Trial with the HBAI20 Hepatitis B Vaccine for Non-Responders
04/29/16
> Cristal Therapeutics Announces Appointment of Edwin Klumper as Chief Medical Officer
04/29/16
> VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration
04/27/16
> ProBioGen and Eucodis Sign Agreement to Commercialize C-LiNK, a Novel Antibody Drug Conjugation Technology
04/19/16
> Agendia’s MammaPrint® First and Only Genomic Assay to Receive Level 1A Clinical Utility Evidence for Chemotherapy Benefit in Early Breast Cancer Patients
04/19/16
> RedHill Biopharma Announces Positive FDA Meeting on RHB-105 Path to Approval and Planned Confirmatory Phase III Study for H. pylori Infection
04/18/16
> Selvita Files IND Application for its Novel, Dual PIM/FLT3 Inhibitor in AML
04/18/16
> MINDACT Trial Findings on Agendia’s MammaPrint to be Presented during AACR Annual Meeting 2016
04/15/16
> Apollo Therapeutics: Dr Richard Butt Appointed CEO
04/14/16
> Tech Transfer: 9th BioVaria to Take Place in Munich on 17 May 2016
04/13/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 3 of 44